Market Overview

UBS Maintains Buy on Gilead Sciences, Inc., Raises PT to $87.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for GILD

DateFirmActionFromTo
Jul 2016Argus ResearchDowngradesBuyHold
Jul 2016NeedhamDowngradesBuyHold
Jun 2016Gabelli & CoInitiates Coverage onBuy

View More Analyst Ratings for GILD
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (GILD)